Refine
Year of publication
Document Type
- Article (50)
- Lecture (18)
- Conference Proceeding (6)
- Part of a Book (1)
Keywords
- Tissue Engineering (22)
- Scaffold (10)
- Biomaterials (9)
- Silk (8)
- Fibrin (7)
- Bioreactor (6)
- Cells (6)
- Tissue Regeneration (6)
- Grafting (5)
- Regeneration (5)
- Shockwave (5)
- Biomaterial (4)
- Stem Cells (4)
- Cartilage (3)
- Cell Culture (3)
- Healing Processes (3)
- Ligament (3)
- Shockwave Therapy (3)
- Biophysical Stimuli (2)
- Bioreactors (2)
- Decellularization (2)
- Fibroin (2)
- In Vitro (2)
- Ligaments (2)
- Nerve Regeneration (2)
- Placenta (2)
- Shockwave treatment (2)
- Signaling (2)
- Surgery (2)
- Tissue Generation (2)
- ACL (1)
- Acellular biological matrices (1)
- Adipose (1)
- Angiogenesis (1)
- Angiogenesis and vasculogenesis (1)
- Anterior Cruciate Ligament (1)
- Atmospheric Pressure (1)
- Cartilage Tissue (1)
- Cartilage regeneration (1)
- Chondrogenic Redifferentiation (1)
- Cruciate Ligament (1)
- Cytocompatibility (1)
- Data Analysis (1)
- ESWT (1)
- EVs (1)
- Endothelial Cells (1)
- Extracorporeal shockwave (1)
- HUVEC (1)
- Hernia Repair (1)
- Hydrogel (1)
- Imaging (1)
- In toto differentiation (1)
- Laser (1)
- Mechanical Testing (1)
- Membrane (1)
- Metabolism (1)
- Micro-Patterning (1)
- Microfluidic (1)
- Muscle (1)
- Muscle Tissue (1)
- Myogenesis (1)
- Nerve Defect (1)
- Nitrite (1)
- Osteoarthritis (1)
- Osteointegration (1)
- Phototherapy (1)
- Reactive oxygen species (1)
- Regenerative Medicine (1)
- Regenerative medicine (1)
- Rotator Cuff Tears (1)
- Scaffold Material (1)
- Sericin (1)
- Spinal Cord Injury (1)
- Tissue Formation (1)
- Vascular Network Formation (1)
- Vascularization (1)
- aging (1)
- arthritis (1)
- bone marrow stromal cells (1)
- bone microarchitecture (1)
- bone regeneration (1)
- bone tissue engineering (1)
- chronic rotator cuff repair (1)
- coculture joint model (1)
- endochondral (1)
- extracellular matrix (1)
- human three-dimensional chip (1)
- hydrogels (1)
- iPSCs (1)
- intramembranous (1)
- mesenchymal stromal cells (1)
- ossification (1)
- osteogenic differentiation (1)
- pseudoarthrosis (1)
- silk fibroin (1)
- silk scaffold (1)
- µCT (1)
Department
Rheumatoid arthritis is characterised by a progressive, intermittent inflammation at the synovial membrane, which ultimately leads to the destruction of the synovial joint. The synovial membrane as the joint capsule's inner layer is lined with fibroblast-like synoviocytes that are the key player supporting persistent arthritis leading to bone erosion and cartilage destruction. While microfluidic models that model molecular aspects of bone erosion between bone-derived cells and synoviocytes have been established, RA's synovial-chondral axis has not yet been realised using a microfluidic 3D model based on human patient in vitro cultures. Consequently, we established a chip-based three-dimensional tissue coculture model that simulates the reciprocal cross talk between individual synovial and chondral organoids. When co-cultivated with synovial organoids, we could demonstrate that chondral organoids induce a higher degree of cartilage physiology and architecture and show differential cytokine response compared to their respective monocultures highlighting the importance of reciprocal tissue-level cross talk in the modelling of arthritic diseases.
Extracorporeal shockwave therapy (ESWT) can stimulate processes to promote regeneration, including cell proliferation and modulation of inflammation. Specific miRNA expression panels have been established to define correlations with regulatory targets within these pathways. This study aims to investigate the influence of low-energy ESWT-applied within the subacute and chronic phase of SCI (spinal cord injury) on recovery in a rat spinal cord contusion model. Outcomes were evaluated by gait analysis, µCT and histological analysis of spinal cords. A panel of serum-derived miRNAs after SCI and after ESWT was investigated to identify injury-, regeneration- and treatment-associated expression patterns. Rats receiving ESWT showed significant improvement in motor function in both a subacute and a chronic experimental setting. This effect was not reflected in changes in morphology, µCT-parameters or histological markers after ESWT. Expression analysis of various miRNAs, however, revealed changes after SCI and ESWT, with increased miR-375, indicating a neuroprotective effect, and decreased miR-382-5p potentially improving neuroplasticity via its regulatory involvement with BDNF. We were able to demonstrate a functional improvement of ESWT-treated animals after SCI in a subacute and chronic setting. Furthermore, the identification of miR-375 and miR-382-5p could potentially provide new targets for therapeutic intervention in future studies.
Regeneration of bone defects is often limited due to compromised bone tissue physiology. Previous studies suggest that engineered extracellular matrices enhance the regenerative capacity of mesenchymal stromal cells. In this study, we used human-induced pluripotent stem cells, a scalable source of young mesenchymal progenitors (hiPSC-MPs), to generate extracellular matrix (iECM) and test its effects on the osteogenic capacity of human bone-marrow mesenchymal stromal cells (BMSCs). iECM was deposited as a layer on cell culture dishes and into three-dimensional (3D) silk-based spongy scaffolds. After decellularization, iECM maintained inherent structural proteins including collagens, fibronectin and laminin, and contained minimal residual DNA. Young adult and aged BMSCs cultured on the iECM layer in osteogenic medium exhibited a significant increase in proliferation, osteogenic marker expression, and mineralization as compared to tissue culture plastic. With BMSCs from aged donors, matrix mineralization was only detected when cultured on iECM, but not on tissue culture plastic. When cultured in 3D iECM/silk scaffolds, BMSCs exhibited significantly increased osteogenic gene expression levels and bone matrix deposition. iECM layer showed a similar enhancement of aged BMSC proliferation, osteogenic gene expression, and mineralization compared with extracellular matrix layers derived from young adult or aged BMSCs. However, iECM increased osteogenic differentiation and decreased adipocyte formation compared with single protein substrates including collagen and fibronectin. Together, our data suggest that the microenvironment comprised of iECM can enhance the osteogenic activity of BMSCs, providing a bioactive and scalable biomaterial strategy for enhancing bone regeneration in patients with delayed or failed bone healing.
Bone grafts can be engineered by differentiating human mesenchymal stromal cells (MSCs) via the endochondral and intramembranous ossification pathways. We evaluated the effects of each pathway on the properties of engineered bone grafts and their capacity to drive bone regeneration. Bone-marrow-derived MSCs were differentiated on silk scaffolds into either hypertrophic chondrocytes (hyper) or osteoblasts (osteo) over 5 weeks of in vitro cultivation, and were implanted subcutaneously for 12 weeks. The pathways' constructs were evaluated over time with respect to gene expression, composition, histomorphology, microstructure, vascularization and biomechanics. Hypertrophic chondrocytes expressed higher levels of osteogenic genes and deposited significantly more bone mineral and proteins than the osteoblasts. Before implantation, the mineral in the hyper group was less mature than that in the osteo group. Following 12 weeks of implantation, the hyper group had increased mineral density but a similar overall mineral composition compared with the osteo group. The hyper group also displayed significantly more blood vessel infiltration than the osteo group. Both groups contained M2 macrophages, indicating bone regeneration. These data suggest that, similar to the body's repair processes, endochondral pathway might be more advantageous when regenerating large defects, whereas intramembranous ossification could be utilized to guide the tissue formation pattern with a scaffold architecture.